category,datetime,headline,id,image,related,source,summary,url
company,1769119547,Assessing Johnson & Johnson (JNJ) Valuation After Recent Share Price Momentum,138219626,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"Why Johnson & Johnson (JNJ) is Back on Investors’ Radar Johnson & Johnson (JNJ) has drawn fresh attention after recent trading left the stock with a month gain of about 5% and a past 3 months return above 13%. Those moves come against the backdrop of its diversified healthcare business, spanning prescription medicines and medical devices, and raise familiar questions for investors about how current pricing lines up with value and long term expectations. See our latest analysis for Johnson &...",https://finnhub.io/api/news?id=21b758bb559c3e5d6ed22b811c6d29881fac5d97b593b570045b4ec721e4c235
company,1769118147,"Earnings live: Intel stock drops, GE Aerospace tumbles, Capital One announces Brex acquisition",138213201,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, Procter & Gamble, and Intel.",https://finnhub.io/api/news?id=35b1532e2b00dd9e07273e77c3ebaa8141978153776c0623c7611d232ae1443d
company,1769101380,ABBV vs. MRK: An Oncology-Immunology Showdown for Investors,138206816,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"ABBV has rebounded after Humira patent cliff, with Skyrizi and Rinvoq driving growth. Rising estimates and a pipeline set to power earnings into 2029 bode well.",https://finnhub.io/api/news?id=dc8e1aee0d5f2a73f309f6897172ff20bf593c3492013eb33d815d6e66f051c6
company,1769100302,Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio,138206840,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",https://finnhub.io/api/news?id=570b657cb6bc595276c9f148332ab0b79992675fcdd9507a1366f62658bf2594
company,1769090760,Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings.,138204655,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,Shares of  Abbott Laboratories  tumbled Thursday after the medical devices maker posted fourth-quarter earnings and sales that underwhelmed Wall Street.  The company said it expects full-year adjusted earnings in the range of $5.55 to $5.80 a share.  Abbott also is targeting full-year organic sales growth of between 6.5% to 7.5%.,https://finnhub.io/api/news?id=57e65b9d82ffaf11e0ab7631f7258f25ffb081a22d9b121213c88c42674c3714
company,1769094485,Playing It Safe at 70 With $2.5 Million Is Likely To Backfire,138205128,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"A 70-year-old investor with $2.5 million in blue-chip dividend stocks faces a question many retirees wrestle with: is playing it safe actually risky? On Reddit’s r/Bogleheads forum, one user questioned whether their early-70s father’s portfolio with just 10% in stocks was too conservative, noting it “seems just almost too conservative, where it’s almost at a ... Playing It Safe at 70 With $2.5 Million Is Likely To Backfire",https://finnhub.io/api/news?id=320a85bf58a307713306e2abbdda76898432fab2c841f75d4da8640f6ebb293c
company,1769093985,Jim Cramer on Johnson & Johnson: “One of the Best Pharmas There Is”,138204582,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"Johnson & Johnson (NYSE:JNJ) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s earnings and the following market reaction, as he stated: Alright, what do we make of these earnings from Johnson & Johnson? This morning, the pharma titan reported a healthy revenue beat and a very modest […]",https://finnhub.io/api/news?id=7e26b45e94ffbd2cd5f79b1cbde8051c1dd45c2c3bc82905bc90d4f4fb70b545
company,1769091300,Is BMY's Deep Pipeline the Key to Its Next Growth Phase?,138205782,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"BMY spotlights a deep pipeline with multi-billion-dollar potential, key late-stage data readouts ahead, and encouraging uptake of the new schizophrenia drug Cobenfy.",https://finnhub.io/api/news?id=e30052199250baef2f56947ed670fb7e5683f6ed6f976ba74c3672c512b334a9
company,1769090670,A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate Reality,138204576,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,A dual-income couple approaching retirement with $1.2 million in savings and Social Security benefits faces a critical question: Will this be enough? The answer depends heavily on coordinating Social Security claims and structuring portfolio withdrawals. The Financial Snapshot Portfolio: $1.2 million in retirement savings Income source: Social Security benefits from dual earners Key challenge: Coordinating ... A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate Reality,https://finnhub.io/api/news?id=7a874664b4434bc3d08ad2f3e89c67ce6f29cff9b0ecc1312ca3ca1b07b210ca
company,1769090404,Why Investors Need to Take Advantage of These 2 Medical Stocks Now,138204584,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.,https://finnhub.io/api/news?id=1a0efe0d2a9a9ecfcfff0e8f64c74b439c8f879b522874013117b946d029fa97
company,1769087950,"Earnings live: GE Aerospace orders surge, Procter & Gamble stock rises, Abbott tumbles",138206841,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, Procter & Gamble, and Intel.",https://finnhub.io/api/news?id=2c6f158e213cf99e008a3817a55c075d6b66de568979edd20fc55183c57a1b0c
company,1769087950,"Earnings live: GE Aerospace orders surge, Procter & Gamble and Abbott stocks dip",138203808,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, Procter & Gamble, and Intel.",https://finnhub.io/api/news?id=0dbc79d78237b39df48b4d83b5c739ecbf08903a9480e2ddda046a19d5163bf3
company,1769081760,FDA lays out new path to speed development of multiple myeloma drugs,138205783,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"In certain cases, regulators will now be open to clearing therapies based on their ability to eliminate tumor cells, a change that could accelerate cell therapies and other new medicines.",https://finnhub.io/api/news?id=7363b089812e65a05c9d5e44d2c6faa56186197442a7a97d0cb631c589035b77
company,1769079797,Johnson & Johnson reports 9.1% increase in sales for Q4 2025,138203092,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"For the entire year, sales grew by 6% to $94.2bn, and full-year earnings per share registered at $11.03.",https://finnhub.io/api/news?id=80b05fb039331af0d02c49900381db3955240eb8088cd132e632037a43ed9a83
company,1769071819,Jim Cramer's top 10 things to watch in the stock market Thursday,138205257,https://image.cnbcfm.com/api/v1/image/108255380-17690331752026-01-21t220523z_286979253_rc2v5ja1vheb_rtrmadp_0_usa-stocks.jpeg?v=1769033262&w=1920&h=1080,JNJ,CNBC,The S&P 500 advanced this morning as Wall Street cheered signs of easing geopolitical tensions. Traders are also awaiting key inflation data.,https://finnhub.io/api/news?id=a020014ef53804cb955cd3b5a01cb07f030f9414918e6f77a73321210a6c3f47
company,1769068800,Resolve M Therapeutics exits from stealth,138202438,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"Resolve M Therapeutics, Inc., the biotech aiming to build the world's first comprehensive pro-resolution platform for target ID, validation and drug discovery for the treatment of inflammatory diseases, has announced its exit from stealth. Resolve M was created through a strategic collaboration between Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc., and General Inception, the global biotech company igniter, and reflects a bold com",https://finnhub.io/api/news?id=c7fee9d8e25182c5475e19293c021cc9da8d9d91875256977fca27e697e06865
company,1769065500,This 2.4%-Yielding Dividend King Remains As Healthy As Ever,138201877,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,Johnson & Johnson had a strong year.,https://finnhub.io/api/news?id=f0956dde66e7481fd593b08b2d31859ed767859d4da85b3e681b647eb98ff5ea
company,1769058060,Housing Market’s Blue Christmas: Pending Sales Slide Most Since 2001,138203810,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"The downturn comes at an interesting time: There are now 47% more sellers than buyers on the market, according to RedFin.",https://finnhub.io/api/news?id=e4abfe23618f060c6556d50fbeb910c423e853240e9f96c1e5f4288134fd9a4d
company,1769058060,"Johnson & Johnson Crushes Patent, Pricing Probs",138203277,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,The company is vying to become the first among its healthcare peers to make $100 billion in annual revenue.,https://finnhub.io/api/news?id=971947ae35deed5c7aaa36c0437223d901199907bef43ba3a8a0a4c84cedaf7d
company,1769050200,Is This Dividend King Stock a Buy After a Major Development?,138200755,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"After a strong performance in 2025, Johnson & Johnson is starting the new year right.",https://finnhub.io/api/news?id=a30d729b439b93a63b1875fd5a31e94485d51f42ee4f303d286a107d45f6000a
